Related references
Note: Only part of the references are listed.Incidence and case fatality rate of COVID-19 in patients with inflammatory articular diseases
Natalia Mena Vazquez et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)
Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study
Satveer K. Mahil et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis
Ofelia Baniandres-Rodriguez et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
COVID-19 in French patients with chronic inflammatory rheumatic diseases: Clinical features, risk factors and treatment adherence
Felicie Costantino et al.
JOINT BONE SPINE (2021)
COVID-19 in patients with cutaneous immune-mediated diseases in The Netherlands: real-world observational data
L. E. M. de Wijs et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience
Paolo Gisondi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
Milena Gianfrancesco et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
The impact of theCOVID-19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience
P. Gisondi et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Biologics increase the risk of SARS-CoV-2 infection and hospitalization, but not ICU admission and death: Real-life data from a large cohort during red-zone declaration
Giovanni Damiani et al.
DERMATOLOGIC THERAPY (2020)
Rate of Patient-Driven Biologic Treatment Discontinuation During the COVID-19 Pandemic in 2 Academic Hospital Clinics at the University of Toronto
Jorge R. Georgakopoulos et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2020)
Against pandemic research exceptionalism
Alex John London et al.
SCIENCE (2020)
Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment
Paolo Gisondi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway-inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic
Marilyn T. Wan et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
Marc Feldmann et al.
LANCET (2020)
Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study
Jose L. Pablos et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Incidence of COVID-19 in Patients With Rheumatic Diseases Treated With Targeted Immunosuppressive Drugs: What Can We Learn From Observational Data?
Ennio Giulio Favalli et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Editorial Evaluation and Peer Review During a Pandemic How Journals Maintain Standards
Howard Bauchner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Lack of Evidence for an Increased Risk of Severe COVID-19 in Psoriasis Patients on Biologics: A Cohort Study from Northeast Italy
Stefano Piaserico et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2020)
Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study
Jorge R. Georgakopoulos et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19
A. -C. Fougerousse et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Severe COVID-19 outcomes in patients with psoriasis
X. T. Lima et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series
Clodoveo Ferri et al.
CLINICAL RHEUMATOLOGY (2020)
Does therapy with biological drugs influence COVID-19 infection? Observational monocentric prevalence study on the clinical and epidemiological data of psoriatic patients treated with biological drugs or with topical drugs alone
Valeria Brazzelli et al.
DERMATOLOGIC THERAPY (2020)
More on Covid-19 in Immune-Mediated Inflammatory Diseases
Luigi Naldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD
Rebecca Hasseli et al.
RMD OPEN (2020)
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case-control study
Micaela Fredi et al.
LANCET RHEUMATOLOGY (2020)
Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces
Martina Vispi et al.
DERMATOLOGY REPORTS (2020)
Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Trials
Alexander C. Ford et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? a systematic review
Raul Herzog et al.
BMC PUBLIC HEALTH (2013)
Testing the Newcastle Ottawa Scale showed low reliability between individual reviewers
Lisa Hartling et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
How to assess the external validity of therapeutic trials: a conceptual approach
O. M. Dekkers et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2010)
Share Paper
